Akciğer Hastalıklarında Elektroterapi Uygulamaları

Yıl 2024, Cilt: 6 Sayı: 1, 44 - 53, 29.02.2024

Fulya Senem Karaahmetoğlu , Esra Pehlivan

https://doi.org/10.57224/jhpr.1093572

Öz

Akciğer hastalıkları; küresel boyutta yüke sebep olan, yaşam kalitesini düşüren ve mortaliye ciddi oranda katkıda bulunan hastalık gruplarındandır. Akciğer hastalıkları; KOAH, bronşektazi, akciğer kanseri, astım ve interstisyel akciğer hastalıkları dahil geniş bir grubu temsil etmektedir. Her bir hastalığın kendi oluş mekanizmasına dair tedavi yöntemleri geliştirilmiş ve geliştirilmektedir. Akciğer hastalıklarında, fizyoterapi ve rehabilitasyon uygulamaları arasında elektroterapi uygulamaları kısmen az uygulanmakla birlikte son yıllarda yapılan çalışmalarla elektroterapi uygulamalarının bu hasta gruplarında kas kuvvet artışının ve ağrı kontrolünün sağlanması, doku iyileşmesinin hızlandırılması, egzersiz kapasitesinin artırılması gibi ilave faydalar sağlayacağı vurgulanmaktadır. Çalışmamız, akciğer hastalıklarında uygulanan elektroterapi uygulamalarına ve bu uygulamaların etkinliği ile ilgili literatüre ışık tutmaktadır.

Anahtar Kelimeler

akciğer hastalıklar, elektroterapi, elektrik stimülasyonu

Electrotherapy in Lung Diseases

Öz

Lung diseases; It is one of the disease groups that cause a global burden, reduce the quality of life and contribute significantly to mortality. Lung diseases; COPD represents a broad group, including bronchiectasis, lung cancer, asthma and interstitial lung diseases. Treatment methods for each disease's own mechanism of occurrence have been developed and are being developed. Although electrotherapy applications are partially applied in lung diseases among physiotherapy and rehabilitation applications, it has been emphasized that electrotherapy applications will provide additional benefits such as muscle strength increase and pain control, acceleration of tissue healing, and increase in exercise capacity in these patient groups. Our study sheds light on the electrotherapy applications applied in lung diseases and the literature on the effectiveness of these applications.

Anahtar Kelimeler

electrotherapy, electrical stimulation, pulmonary diseases

Kaynakça

• 1. Glass RI, Rosenthal JP. International approach to environmental and lung health a perspective from the fogarty international center. Ann Am Thorac Soc. 2018;15(2):S109-S113.
• 2. Tiktinsky R, Chen L, Narayan P. Electrotherapy: Yesterday, today and tomorrow. Haemophilia. 2010;16(5):126-31.
• 3. Yakut E. Kanıta Dayalı Elektroterapi. 1st ed. Yakut E, Dalkılınç M, Kaya D, editors. Kanıta Dayalı Elektroterapi. Ankara: Lippincott Williams & Wilkins; 2008.
• 4. Halpin DMG, Criner GJ, Papi A, Singh D, Anzueto A, Martinez FJ, et al. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021;203(1):24-36.
• 5. Maddocks M, Nolan CM, Man WDC, Polkey MI, Hart N, Gao W, et al. Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: A randomised double-blind, placebo-controlled trial. Lancet Respir Med. 2016;4(1):27-36.
• 6. Chen RC, Li XY, Guan LL, Guo BP, Wu WL, Zhou ZQ, et al. Effectiveness of neuromuscular electrical stimulation for the rehabilitation of moderate-to-severe COPD: A meta-analysis. Int J COPD. 2016;11:2965-2975.
• 7. Wu X, Hu X, Hu W, Xiang G, Li S. Effects of neuromuscular electrical stimulation on exercise capacity and quality of life in COPD patients: A systematic review and meta-analysis. Biosci Rep. 2020;40(5):BSR20191912.
• 8. Medrinal C, Prieur G, Combret Y, Quesada AR, Debeaumont D, Bonnevie T, et al. Functional Electrical Stimulation—A New Therapeutic Approach to Enhance Exercise Intensity in Chronic Obstructive Pulmonary Disease Patients: A Randomized, Controlled Crossover Trial. Arch Phys Med Rehabil. 2018;99(8):1454-1461.
• 9. Maruoka H, Tanaka K, Takayanagi M, Zenda M. Effects of neuromuscular electrical stimulation on pulmonary alveola and cytokines in chronic obstructive pulmonary disease (COPD) and skeletal muscle atrophy model mice. J Phys Ther Sci. 2021;33(1):1-8.
• 10. Bonnevie T, Gravier FE, Prieur G, Combret Y, Patout M, Lamia B, et al. Lumbar transcutaneous electrical nerve stimulation to improve exercise performance in COPD patients. Eur Respir J. 2019;54(6):1900784.
• 11. Latimer LE, Constantin D, Greening NJ, Calvert L, Menon MK, Steiner MC, et al. Impact of transcutaneous neuromuscular electrical stimulation or resistance exercise on skeletal muscle mRNA expression in COPD. Int J COPD. 2019;14:1355-1364.
• 12. Mekki M, Paillard T, Sahli S, Tabka Z, Trabelsi Y. Effect of adding neuromuscular electrical stimulation training to pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: randomized clinical trial. Clin Rehabil. 2019;33(2):195-206.
• 13. Ngai SPC, Spencer LM, Jones AYM, Alison JA, Vemulpad S. Acu-TENS reduces breathlessness during exercise in people with chronic obstructive pulmonary disease. Evidence-based Complement Altern Med. 2017;2017:3649257.
• 14. Xiao X, Li S, Wang Y, Lei DM, Zhang X, Zhao FR, et al. Effect of transcutaneous electrical acupoint stimulation on lung function and risks of exacerbation for patients with chronic obstructive pulmonary disease. Zhen Ci Yan Jiu. 2021;46(7):598-604.
• 15. Acheche A, Mekki M, Paillard T, Tabka Z, Trabelsi Y. The Effect of Adding Neuromuscular Electrical Stimulation with Endurance and Resistance Training on Exercise Capacity and Balance in Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. Can Respir J. 2020;2020:9826084.
• 16. Jones S, Man WDC, Gao W, Higginson IJ, Wilcock A, Maddocks M. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database Syst Rev. 2016;10(10):CD009419.
• 17. Hill K, Cavalheri V, Mathur S, Roig M, Janaudis-Ferreira T, Robles P, et al. Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018;5(5):CD010821.
• 18. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-65.
• 19. Öncü E, Zincir H. The effect of transcutaneous electrical nerve stimulation in patients with acute exacerbation of chronic obstructive pulmonary disease: randomised controlled trial. J Clin Nurs. 2017;26(13–14):1834-1844.
• 20. Meys R, Sillen MJ, Franssen FME, Stoffels AAF, Wouters EFM, van Hees HWH, et al. Impact of mild-to-moderate exacerbations on outcomes of neuromuscular electrical stimulation (NMES) in patients with COPD. Respir Med. 2020;161:105851.
• 21. Lopez-Lopez L, Torres-Sanchez I, Rodriguez-Torres J, Cabrera-Martos I, Cahalin LP, Valenza MC. Randomized feasibility study of twice a day functional electrostimulation in patients with severe chronic obstructive pulmonary disease hospitalized for acute exacerbation. Physiother Theory Pract. 2021;37(12):1360-1367.
• 22. Chen S, Jiang Y, Yu B, Dai Y, Mi Y, Tan Y, et al. Effect of transcutaneous neuromuscular electrical stimulation on prevention of intensive care unit-acquired weakness in chronic obstructive pulmonary disease patients with mechanical ventilation. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31(6):709-713.
• 23. Akar O, Günay E, Sarinc Ulasli S, Ulasli AM, Kacar E, Sariaydin M, et al. Efficacy of neuromuscular electrical stimulation in patients with COPD followed in intensive care unit. Clin Respir J. 2017;11(6):743-750.
• 24. Franssen FME, Vanfleteren LEGW, Janssen DJA, Wouters EFM, Spruit MA. Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure. Breathe. 2019;15(3):227-233.
• 25. Gutiérrez-Arias RE, Zapata-Quiroz CC, Prenafeta-Pedemonte BO, Nasar-Lillo NA, Gallardo-Zamorano DI. Effect of neuromuscular electrical stimulation on the duration of mechanical ventilation. Respir Care. 2021;66(4):679-685.
• 26. Ambrosino N, Fracchia C. Strategies to relieve dyspnoea in patients with advanced chronic respiratory diseases. A narrative review. Pulmonology. 2019;25(5):289-298.
• 27. Neder JA, Sword D, Ward SA, Mackay E, Cochrane LM, Clark CJ. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax. 2002;57(4):333-7.
• 28. Valenza MC, Torres-Sánchez I, López-López L, Cabrera-Martos I, Ortiz-Rubio A, Valenza-Demet G. Effects of home-based neuromuscular electrical stimulation in severe chronic obstructive pulmonary disease patients: A randomized controlled clinical trial. Eur J Phys Rehabil Med. 2018;54(3):323-332.
• 29. Bonnevie T, Gravier FE, Debeaumont D, Viacroze C, Muir JF, Cuvelier A, et al. Home-based Neuromuscular Electrical Stimulation as an Add-on to Pulmonary Rehabilitation Does Not Provide Further Benefits in Patients With Chronic Obstructive Pulmonary Disease: A Multicenter Randomized Trial. Arch Phys Med Rehabil. 2018;99(8):1462-1470.
• 30. Carpaij OA, Burgess JK, Kerstjens HAM, Nawijn MC, van den Berge M. A review on the pathophysiology of asthma remission. Pharmacol Ther. 2019;201:8-24.
• 31. Spruit MA, Singh SJ, Garvey C, Zu Wallack R, Nici L, Rochester C, et al. An official American thoracic society/European respiratory society statement: Key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-64.
• 32. Elnaggar RK, Moawd SA, Ali SE, Yousef AM, Azab AR. Potential impacts of Acu-TENS in the treatment of adolescents with moderate to severe bronchial asthma: A randomized clinical study. Complement Ther Med. 2021;57:102673.
• 33. Rodriguez-Canales J, Parra-Cuentas E, Wistuba II. Diagnosis and molecular classification of lung cancer. Cancer Treat Res. 2016;170:25-46.
• 34. Tu Q, Yang Z, Gan J, Zhang J, Que B, Song Q, et al. Transcutaneous electrical acupoint stimulation improves immunological function during the perioperative period in patients with non-small cell lung cancer undergoing video-assisted thoracic surgical lobectomy. Technol Cancer Res Treat. 2018;17:1533033818806477.
• 35. Zhou J, Dan Y, Yixian Y, Lyu M, Zhong J, Wang Z, et al. Efficacy of Transcutaneous Electronic Nerve Stimulation in Postoperative Analgesia after Pulmonary Surgery: A Systematic Review and Meta-Analysis. Am J Phys Med Rehabil. 2020;99(3):241-249.
• 36. Chen J, Zhang Y, Li X, Wan Y, Ji X, Wang W, et al. Efficacy of transcutaneous electrical acupoint stimulation combined with general anesthesia for sedation and postoperative analgesia in minimally invasive lung cancer surgery: A randomized, double-blind, placebo-controlled trial. Thorac Cancer. 2020;11(4):928-934.
• 37. Fiorelli A, Morgillo F, Milione R, Pace MC, Passavanti MB, Laperuta P, et al. Control of post-thoracotomy pain by transcutaneous electrical nerve stimulation: Effect on serum cytokine levels, visual analogue scale,pulmonary function and medication. Eur J Cardio-thoracic Surg. 2012;41(4):861-8.
• 38. Burgel PR, Fajac I. Cystic fibrosis: Current aspects and perspectives. Press Medicale. 2017;46(6 Pt 2):e85-e86.
• 39. Vivodtzev I, Decorte N, Wuyam B, Gonnet N, Durieu I, Levy P, et al. Benefi ts of neuromuscular electrical stimulation prior to endurance training in patients with cystic fibrosis and severe pulmonary dysfunction. Chest. 2013;143(2):485-493.
• 40. Poncin W, Evrard S, Mareschal A, Gohy S, Reychler G. Effects of rehabilitation methods on lower-limb muscle function and functional performance in patients with cystic fibrosis: A systematic review. Clin Rehabil. 2021;35(4):534-545.
• 41. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the european society of cardiology (ESC) and the european respiratory society (ERS): Endor. Russ J Cardiol. 2016;37(1):67-119.
• 42. Kahraman BO, Savci S, Ozsoy I, Baran A, Acar S, Ozpelit E, et al. Effects of neuromuscular electrical stimulation in patients with pulmonary arterial hypertension: a randomized controlled pilot study. J Cardiol. 2020;75(6):702-708.
• 43. Arena R, Lavie CJ, Borghi-Silva A, Daugherty J, Bond S, Phillips SA, et al. Exercise Training in Group 2 Pulmonary Hypertension: Which Intensity and What Modality. Prog Cardiovasc Dis. 2016;59(1):87-94.
• 44. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, et al. The Berlin definition of ARDS: An expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573-82.
• 45. Ambrosino N, Makhabah DN. Comprehensive physiotherapy management in ARDS. Minerva Anestesiol. 2013;79(5):554-63.
• 46. Ozyemisci Taskiran O, Turan Z, Tekin S, Senturk E, Topaloglu M, Yurdakul F, et al. Physical rehabilitation in intensive care unit in acute respiratory distress syndrome patients with COVID-19. Eur J Phys Rehabil Med. 2021;57(3):434-442.
• 47. Travis WD, King TE, Bateman ED, Lynch DA, Capron F, Center D, et al. American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165(2):277-304.
• 48. López-López L, Torres-Sánchez I, Rodríguez-Torres J, Cabrera-Martos I, Ortiz-Rubio A, Valenza MC. Does adding an integrated physical therapy and neuromuscular electrical stimulation therapy to standard rehabilitation improve functional outcome in elderly patients with pneumonia? A randomised controlled trial. Clin Rehabil. 2019;33(11):1757-1766.
• 49. Rivera-Ortega P, Molina-Molina M. Interstitial lung diseases in developing countries. Ann Glob Heal. 2019;85(1):4.
• 50. Nolan CM, Patel S, Barker RE, Walsh JA, Polgar O, Maddocks M, et al. Muscle stimulation in advanced idiopathic pulmonary fibrosis: A randomised placebo-controlled feasibility study. BMJ Open. 2021;11(6):e048808.